These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36984501)

  • 21. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Non-alcoholic Fatty Liver Disease Detected by Computed Tomography in the General Population Compared with Ultrasonography.
    Ito Y; Yoshioka K; Hayashi K; Shimizu Y; Fujimoto R; Yamane R; Yoshizaki M; Kajikawa G; Mizutani T; Goto H
    Intern Med; 2024 Jan; 63(2):159-167. PubMed ID: 37225482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis).
    Tison GH; Blaha MJ; Nasir K; Blumenthal RS; Szklo M; Ding J; Budoff MJ
    Am J Cardiol; 2015 Aug; 116(4):541-6. PubMed ID: 26070222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.
    Dasarathy J; Periyalwar P; Allampati S; Bhinder V; Hawkins C; Brandt P; Khiyami A; McCullough AJ; Dasarathy S
    Liver Int; 2014 Jul; 34(6):e118-27. PubMed ID: 24118743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors.
    Lee S; Kim KW; Lee J; Park T; Koo K; Song GW; Lee SG
    Transplant Proc; 2022 Apr; 54(3):702-705. PubMed ID: 35256204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results.
    Gaba RC; Knuttinen MG; Brodsky TR; Palestrant S; Omene BO; Owens CA; Bui JT
    Diagn Interv Radiol; 2012; 18(3):282-7. PubMed ID: 22258794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.
    Radmard AR; Rahmanian MS; Abrishami A; Yoonessi A; Kooraki S; Dadgostar M; Hashemi Taheri AP; Gerami Seresht M; Poustchi H; Jafari E; Malekzadeh R; Merat S
    Arch Iran Med; 2016 Oct; 19(10):693-699. PubMed ID: 27743433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation.
    Sawazaki H; Kitamura Y; Yagi K; Arai Y
    Urol Int; 2020; 104(5-6):425-430. PubMed ID: 32396918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol.
    Jang S; Lee CH; Choi KM; Lee J; Choi JW; Kim KA; Park CM
    World J Gastroenterol; 2011 Jul; 17(28):3335-41. PubMed ID: 21876622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
    Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
    Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
    Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
    Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors.
    Babusik P; Bilal M; Duris I
    Med Princ Pract; 2012; 21(1):56-62. PubMed ID: 22024606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.